Indication
Metastasis to Soft Tissue
1 clinical trial
1 product
Product
ANK-101Clinical trial
A Phase I Open-Label, Dose Escalation Study of the Safety and Tolerability of ANK-101 in Advanced Solid TumorsStatus: Recruiting, Estimated PCD: 2025-07-01